L

Lyell Immunopharma
D

LYEL

16.475
USD
-0.43
(-2.51%)
مغلق
حجم التداول
781
الربح لكل سهم
-12
العائد الربحي
-
P/E
-1
حجم السوق
316,504,553
الأخبار المقالات

العنوان: Lyell Immunopharma Inc

القطاع: Healthcare
الصناعة: Biotechnology
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.